全文获取类型
收费全文 | 410篇 |
免费 | 18篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 12篇 |
妇产科学 | 3篇 |
基础医学 | 31篇 |
口腔科学 | 5篇 |
临床医学 | 21篇 |
内科学 | 120篇 |
神经病学 | 58篇 |
特种医学 | 7篇 |
外科学 | 37篇 |
综合类 | 2篇 |
预防医学 | 24篇 |
眼科学 | 1篇 |
药学 | 34篇 |
中国医学 | 1篇 |
肿瘤学 | 69篇 |
出版年
2023年 | 2篇 |
2022年 | 3篇 |
2021年 | 4篇 |
2020年 | 4篇 |
2019年 | 4篇 |
2018年 | 8篇 |
2017年 | 5篇 |
2016年 | 6篇 |
2015年 | 12篇 |
2014年 | 12篇 |
2013年 | 30篇 |
2012年 | 14篇 |
2011年 | 18篇 |
2010年 | 11篇 |
2009年 | 14篇 |
2008年 | 25篇 |
2007年 | 32篇 |
2006年 | 31篇 |
2005年 | 19篇 |
2004年 | 28篇 |
2003年 | 17篇 |
2002年 | 11篇 |
2001年 | 7篇 |
2000年 | 7篇 |
1999年 | 9篇 |
1998年 | 6篇 |
1997年 | 3篇 |
1996年 | 4篇 |
1995年 | 2篇 |
1994年 | 6篇 |
1993年 | 2篇 |
1992年 | 6篇 |
1991年 | 4篇 |
1990年 | 5篇 |
1989年 | 6篇 |
1988年 | 2篇 |
1987年 | 6篇 |
1985年 | 5篇 |
1984年 | 8篇 |
1983年 | 2篇 |
1982年 | 7篇 |
1981年 | 2篇 |
1976年 | 4篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1970年 | 1篇 |
1967年 | 1篇 |
1966年 | 5篇 |
1962年 | 1篇 |
1960年 | 1篇 |
排序方式: 共有428条查询结果,搜索用时 15 毫秒
71.
72.
73.
Anna Basso Erminio Capitani Silvia Moraschini 《Cortex; a journal devoted to the study of the nervous system and behavior》1982,18(3):469-475
The influence of sex on recovery from aphasia was investigated for oral expression and auditory verbal comprehension separately in 264 males and 121 females subdivided according to presence/absence of rehabilitation. The conclusions were that females recover significantly better than males in oral expression, but not in auditory verbal comprehension.These results are discussed with regard to the possible existence of a different cerebral organization in males and females. 相似文献
74.
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) was given by gavage to pregnant rats on the 1st–3rd days of gestation in dosages of 0 (control), 0.125, 0.5, and 2 μg/kg/day. The treatment did not increase pre- and postimplantation losses. Mean fetal weight was reduced at the 0.5 and 2 μg/kg dose levels. 相似文献
75.
76.
77.
The presence of IgM paraproteinemia in low-grade lymphomas is usually considered a clinical syndrome known as Waldenstrom's macroglobulinemia (WM). In the WHO classification, WM is associated to lymphoplasmacytic lymphoma (LPL); it is a clinicopathologic entity characterized by a monoclonal expansion of predominantly small B-lymphocytes with variable plasmacytoid differentiation. LPL constitutes less than 5% of all NHL and it is associated with hepatitis C virus infection in 26% of cases. Cells of LPL/WM are B cells positive for monocytic Ig light chains, IgM, pan-B-cell markers, and negative for CD3 and CD103. The t(9;14)(p13;q32) is present in 50% of LPL, and determines PAX-5 over-expression. 6q21 deletion is observed in 42% of cases. LPL occurs in older adults. Clinical presentation usually consists of disseminated disease, but extranodal involvement and leukemic phase are rare. Most WM patients have symptoms attributable to tumour infiltration and/or monoclonal protein. In fact, a monoclonal serum paraprotein of IgM type and hyperviscosity symptoms may occur in more than 20% of cases (WM). Hyperviscosity syndrome is usually manifested by bleeding, blurring or loss of vision, dizziness, headache, and neurologic symptoms. Malignant infiltration of the CNS (Bing-Neel syndrome) is uncommon. LPL/WM is an indolent malignancy that is not usually curable with conventional treatments. The median survival of patients with LPL or WM is 50-60 months, transformation to large cell lymphoma may occur. Stage definition is irrelevant in WM considering that initiation of therapy is decided on the bases of prognostic factors and the development of disease-related symptoms and signs. The main adverse prognostic factors are older age, B symptoms, anemia, low albumin serum levels, raised SGOT, and high beta 2-microglobulin values. Several therapeutic alternatives for newly diagnosed or relapsed LPL/WM are available; however, the best location for every strategy is a matter of investigation. Several new drugs are being assessed in prospective trials. As a significant progress in this field, response criteria and therapeutic recommendations were updated during the Third International Workshop on WM (7-10 October 2004, Paris, France). 相似文献
78.
79.
80.
Pier Luigi Zinzani Monia Marchetti Atto Billio Giovanni Barosi Angelo Michele Carella Mario Lazzarino Maurizio Martelli Alessandro Rambaldi Luigi Rigacci Corrado Tarella Umberto Vitolo Sante Tura 《American journal of hematology》2013,88(3):185-192
By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issued in 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmunotherapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was also recommended in responding patients. In patients relapsing after an interval longer than 12 months from frontline therapy, we recommended chemoimmunotherapy with non cross‐resistant regimens followed by rituximab maintenance. High dose chemotherapy followed by hematopoietic stem cell transplant was recommended for young fit patients who achieve a response after salvage chemoimmunotherapy. Am. J. Hematol. 88:185–192, 2013. © 2012 Wiley Periodicals, Inc. 相似文献